Bodisen Biotech Suffers Product and Raw Material Loss Due to Flooding
SHAANXI, China, Aug. 13, 2007 (PRIME NEWSWIRE) -- Bodisen Biotech, Inc. (the ``Company'') (Other OTC:BBCZ.PK - News) (LSE:BODI.L - News) (website: http://www.bodisen.com) announced today that flooding due to a significant thunderstorm caused uninsured loss of product and raw materials at its facilities in Yangling. Preliminary estimates by the Company put those losses at up to 1.5 million USD.
The storm, which struck on August 8, caused massive flooding and power outages in many areas of Shaanxi province, was described in local press accounts as the worst in ten years. Despite heroic efforts by employees at both of the Company's Yangling facilities to limit damages, substantial loss was suffered. Despite this event, production continues at both facilities without significant disruption of operations after the storm passed. Photographs and local press accounts of the storm and its aftermath may be accessed at the Company's website: www. bodisen.com at the tab marked ``storm''.
About Bodisen Biotech, Inc.
Bodisen Biotech, Inc. is a leading manufacturer of liquid and organic compound fertilizers, pesticides, insecticides and agricultural raw materials certified by the Petroleum Chemical Industry Administrative office of China (Chemical Petroleum Production Administrative Bureau), Shaanxi provincial government and Chinese government. The Company is headquartered in Shaanxi province and is a Delaware Corporation. The Company's environmentally friendly ``green'' products have been proven to improve soil and plant quality and increase crop yields.
Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of the ``safe harbor'' provisions of the Private Securities Litigation Reform Act of 1995. These statements are based on the current expectations or beliefs of Bodisen Biotech, Inc. management and are subject to a number of factors and uncertainties, and the outcome of events may differ materially from those described in the forward-looking statements.
Contact: Bodisen Biotech, Inc.